Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Frequency: Once per day (subcutaneous), preferably in the evening
By attenuating multiple pathological pathways simultaneously, GHK-Cu contrasts with traditional single-target AD drugs
Join the waitlist and pick your launch-day deal below prices update live
ARA-290 has demonstrated: Regeneration of small nerve fibers Improvement in autonomic symptoms Reduced neuropathic pain Sarcoidosis-Associated Neuropathy In inflammatory conditions such as sarcoidosis, ARA-290 has been shown to: Reduce nerve inflammation Improve pain and fatigue Support nerve recovery Kidney Protection Because erythropoietin signaling plays a role in renal protection, ARA-290 has been studied for: Reducing renal inflammation Limiting ischemic kidney injury Preserving tubular function Autoimmune and Inflammatory Conditions Although not a classic autoimmune therapy, ARA-290s ability to calm inflammatory signaling makes it relevant in conditions characterized by immune-mediated tissue injury
In postsynaptic neurons, Ca 2+ influx promotes phosphorylation of CREB through binding to CRE, resulting in the activation of BDNF transcription [178]
US$ 29.27
US$ 20.15
US$ 28.45
US$ 25.26
